Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
Aurora Cannabis reaffirmed its advice that shareholders take no action on Curaleaf's hostile takeover bid, noting Curaleaf has yet to formally file a revised offer. Curaleaf announced its intention to revise the bid to US$5.00 per Aurora share — 0.4013 subordinate voting shares plus US$1.00 cash — and extended the offer expiry to December 4, 2026. Aurora also claimed victory at the Alberta Securities Commission: Curaleaf agreed to add pro forma financials to its circular and extend the bid period, addressing deficiencies Aurora identified.
Key figures
- Deal Value Usd
- US$5.00 per share
- Exchange ratio
- 0.4013
- Revised bid expiry
- December 4, 2026, 11:59pm MT
- Cash component per share usd
- 1
- Board recommendation due within days
- 15
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.